Humoral and Cellular Immunogenicity for Gene Therapy

Time: 10:30 am
day: Day One


  • Discussing the importance of immunogenicity evaluation for gene therapy viral vectors
  • Comparing methods to evaluate humoral and cellular immunogenicity.
  • Examining published findings that evaluate correlation between assays and clinical relevance will be presented, along with considerations for development of immunogenicity assays for diagnostic purposes